The Robot Report said on 15 October 2026 that Stryker has invested about $400 million in CMR Surgical, with an exclusive option to acquire the company's remaining equity, and has secured an exclusive US commercial agency agreement for the Versius surgical-robot portfolio.
What it means for your work
A major device maker taking a route to own a surgical-robot platform raises the competitive stakes in robotic surgery, especially in the US.
Our read on the items that move something. The reporting is everyone's; this part is ours.
1
A dedicated AI office at the largest US biomedical funder is likely to become the place that sets AI policy for NIH-funded research.NIH proposes creating an Office of the Chief Artificial Intelligence OfficerThe Healthcare Operations beat · Federal Register (National Institutes of Health)
2
Sponsored access lowers the cost barrier for university biology groups to try a domain-specific frontier model.OpenAI offers academic labs sponsored access to GPT-RosalindThe Healthcare Operations beat · OpenAI
3
Faster entry into first-in-human trials shortens the path for new therapies, including the longevity drugs this corpus tracks.FDA details an Expedited IND pilot to speed up first-in-human clinical trialsThe Healthcare Operations beat · US Food and Drug Administration
Following opens with early access — sign up for early access to register your interest; it does not switch following on today. Everything you follow will land on one page, in your account menu.
All coverage
Everything Intel has read, newest first. Each title opens at its original publisher.
Anyone who abandoned ordinary health, clinical or biology-teaching work in a Claude product because it kept refusing has a concrete reason to retry it — and a named list of topics that still will not go through.